Regulation of c-Myc ubiquitination controls chronic myelogenous leukemia initiation and progression

Linsey Reavie, Shannon M. Buckley, Evangelia Loizou, Shoichiro Takeishi, Beatriz Aranda-Orgilles, Delphine Ndiaye-Lobry, Omar Abdel-Wahab, Sherif Ibrahim, Keiichi I. Nakayama, Iannis Aifantis

研究成果: ジャーナルへの寄稿記事

65 引用 (Scopus)

抜粋

The molecular mechanisms regulating leukemia-initiating cell (LIC) function are of important clinical significance. We use chronic myelogenous leukemia (CML) as a model of LIC-dependent malignancy and identify the interaction between the ubiquitin ligase Fbw7 and its substrate c-Myc as a regulator of LIC homeostasis. Deletion of Fbw7 leads to c-Myc overexpression, p53-dependent LIC-specific apoptosis, and the eventual inhibition of tumor progression. A decrease of either c-Myc protein levels or attenuation of the p53 response rescues LIC activity and disease progression. Further experiments showed that Fbw7 expression is required for survival and maintenance of human CML LIC. These studies identify a ubiquitin ligase:substrate pair regulating LIC activity, suggesting that targeting of the Fbw7:c-Myc axis is an attractive therapy target in refractory CML.

元の言語英語
ページ(範囲)362-375
ページ数14
ジャーナルCancer Cell
23
発行部数3
DOI
出版物ステータス出版済み - 3 18 2013

All Science Journal Classification (ASJC) codes

  • Oncology
  • Cell Biology
  • Cancer Research

フィンガープリント Regulation of c-Myc ubiquitination controls chronic myelogenous leukemia initiation and progression' の研究トピックを掘り下げます。これらはともに一意のフィンガープリントを構成します。

  • これを引用

    Reavie, L., Buckley, S. M., Loizou, E., Takeishi, S., Aranda-Orgilles, B., Ndiaye-Lobry, D., Abdel-Wahab, O., Ibrahim, S., Nakayama, K. I., & Aifantis, I. (2013). Regulation of c-Myc ubiquitination controls chronic myelogenous leukemia initiation and progression. Cancer Cell, 23(3), 362-375. https://doi.org/10.1016/j.ccr.2013.01.025